- Home
- IZM vs ANTX Comparison
IZM vs ANTX Comparison
Compare IZM & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IZM | ANTX |
|---|---|---|
| Founded | 2011 | 2017 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.2M | 31.2M |
| IPO Year | 2023 | 2022 |
Fundamental Metrics
Financial Performance| Metric | IZM | ANTX |
|---|---|---|
| Price | $2.10 | $1.32 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | ★ 193.6K | 57.8K |
| Earning Date | 10-24-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $187,048,691.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $25.50 | ★ N/A |
| Revenue Growth | ★ 5.12 | N/A |
| 52 Week Low | $0.87 | $1.00 |
| 52 Week High | $2.74 | $1.55 |
Technical Indicators
Market Signals| Indicator | IZM | ANTX |
|---|---|---|
| Relative Strength Index (RSI) | 58.06 | 68.01 |
| Support Level | $1.80 | $1.00 |
| Resistance Level | $2.73 | $1.14 |
| Average True Range (ATR) | 0.32 | 0.09 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 64.61 | 85.74 |
Price Performance
Historical ComparisonAbout IZM ICZOOM Group Inc.
ICZOOM Group Inc. operates an e-commerce platform selling electronic components to SMEs in China across consumer electronics, IoT, automotive, and industrial control sectors. It offers two main product categories: semiconductor products, including integrated circuits and optoelectronics, and electronic equipment and tools such as electromechanical and MRO supplies. The company also provides services like customs clearance, temporary warehousing, and logistics, earning additional commission fees. The majority of its revenue comes from electronic component sales.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.